The Safety Pharmacology Society is pleased to announce three NEW webinars to kick off 2015! In addition, the recording from the November Webinar on Cardiac Safety Testing is now available.
CiPA (Comprehensive In Vitro Pro-Arrhythmia Assay) is a scientific CSRC/HESI/FDA/SPS-sponsored proposal that aims to define a novel integrated preclinical in vitro/in silico paradigm in which the proarrhythmic potential of new drugs would be primarily assessed using nonclinical in vitro human models
On behalf of the Society, I am pleased to announce that registration is now open for the CSRC/HESI/FDA/SPS CIPA Update Workshop on December 11, 2014. This is a follow-up meeting to the July 2013 workshop on Rechanneling the Current Cardiac Paradigm.
The workshop will be held at the